Tuesday, November 12, 2013
Half dose of MRI contrast feasible for rheumatoid arthritis
A half dose of the MRI contrast agent gadobenate dimeglumine provides just as much relevant diagnostic information as a full dose in 3-tesla imaging of patients with early rheumatoid arthritis, according to a study published in the July issue of Radiology.
The researchers did find, however, that the full dose of gadobenate dimeglumine had significantly better signal-to-noise and contrast-to-noise ratios than the half dose. The mean signal-to-noise ratio was 42.91 for the half dose, compared with 54.22 for the full dose, while the mean contrast-to-noise ratio was 12.81 for the half dose, compared with 24.78 for the full dose.
Despite the disparity in contrast-to-noise and signal-to-noise ratios between the dosages, the diagnostic quality of the images was not affected, according to the authors. No region of synovial inflammation seen on full-dose contrast-enhanced MRI was missed at half dose.
Posted by turbospinecho at Tuesday, November 12, 2013
- Pianissimo™ unparalleled noise reduction with Tosh...
- Half dose of MRI contrast feasible for rheumatoid ...
- CE credits here: Emerging Concepts in Atypical Fem...
- Researchers find unexpected genetic mosaic in the ...
- Siemens Symbia Intevo SPECT/CT
- MRI Interventions to Present at 2013 Canaccord Gen...
- New Knee Ligament- MSK Radiologists Beware
- ▼ November 2013 (7)
- ► 2008 (35)
- ► 2007 (71)